These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9654255)

  • 1. Antithrombotics for left-ventricular impairment?
    Ezekowitz M
    Lancet; 1998 Jun; 351(9120):1904. PubMed ID: 9654255
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombosis and embolism in pediatric cardiomyopathy.
    Chen K; Williams S; Chan AK; Mondal TK
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):221-30. PubMed ID: 23429248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model.
    Arimura T; Sato R; Machida N; Bando H; Zhan DY; Morimoto S; Tanaka R; Yamane Y; Bonne G; Kimura A
    J Am Coll Cardiol; 2010 Apr; 55(14):1503-5. PubMed ID: 20359603
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible cardiomyopathy.
    Dhadke SV; Dhadke VN
    J Assoc Physicians India; 2006 Sep; 54():740-1. PubMed ID: 17212027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block?
    Filippatos G; Kremastinos DT
    Eur Heart J; 2007 May; 28(9):1170-1. PubMed ID: 17412729
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
    Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
    Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: results from a national population-based study of childhood cardiomyopathy.
    Alexander PM; Daubeney PE; Nugent AW; Lee KJ; Turner C; Colan SD; Robertson T; Davis AM; Ramsay J; Justo R; Sholler GF; King I; Weintraub RG;
    Circulation; 2013 Oct; 128(18):2039-46. PubMed ID: 24036608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy.
    Parsons S; Clark AL; Cleland JG
    Clin Res Cardiol; 2014 Oct; 103(10):847-9. PubMed ID: 24920068
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of individual response to heart failure therapy.
    Bax JJ; Delgado V
    Eur Heart J; 2012 Mar; 33(5):567-9. PubMed ID: 22108836
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure].
    Anguita Sánchez M; Rodríguez Esteban M; Ojeda Pineda S; Ruiz Ortiz M; Romo Peña E; Mesa Rubio D; Vallés Belsué F
    Rev Esp Cardiol; 2004 Sep; 57(9):834-41. PubMed ID: 15373989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
    Givertz MM; Andreou C; Conrad CH; Colucci WS
    Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Normalisation of left ventricular function after 13 months of mechanical circulatory support].
    Gustafsson F; Møller JE; Hansen PB; Andersen CB; Olsen PS; Sander K
    Ugeskr Laeger; 2010 May; 172(19):1463-4. PubMed ID: 20470660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers and reverse remodeling: what are the implications?
    Francis GS; Tang WH
    Am Heart J; 2003 Feb; 145(2):200-2. PubMed ID: 12595832
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
    Birks EJ; George RS; Hedger M; Bahrami T; Wilton P; Bowles CT; Webb C; Bougard R; Amrani M; Yacoub MH; Dreyfus G; Khaghani A
    Circulation; 2011 Feb; 123(4):381-90. PubMed ID: 21242487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.
    Kühl U; Pauschinger M; Schwimmbeck PL; Seeberg B; Lober C; Noutsias M; Poller W; Schultheiss HP
    Circulation; 2003 Jun; 107(22):2793-8. PubMed ID: 12771005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.
    Crespo MJ; Cangiano JL; Altieri PI; Escobales N
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):547-52. PubMed ID: 22370958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
    Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotics for left-ventricular impairment.
    Lip GY; Gibbs CR
    Lancet; 1998 Sep; 352(9130):817-8. PubMed ID: 9737312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.